Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Operational Feasibility, Impact of Additional Screening Using Highly-sensitives RDTs Combined With High Coverage of IPTp on Placental Malaria and Low Birth Weight

NCT04147546 is registered in ClinicalTrials.gov with Institut de Recherche en Sciences de la Sante, Burkina Faso as lead sponsor.

NCT NCT04147546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Operational Feasibility, Impact of Additional Screening Using Highly-sensitives RDTs Combined With High Coverage of IPTp on Placental Malaria and Low Birth Weight
Lead sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2020
Completion date
December 31, 2021
Enrollment
340 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria diagnosis, plasmodium falciparum malaria